Research Analysts Set Expectations for ASND Q1 Earnings
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Analysts at Wedbush decreased their Q1 2025 earnings estimates for shares of Ascendis Pharma A/S in a research note issued on Wednesday, February 12th. Wedbush analyst Y. Zhong now forecasts that the biotechnology company will post earnings per share of ($1.76) for the quarter, down from their […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) – Analysts at Wedbush decreased their Q1 2025 earnings estimates for shares of Ascendis Pharma A/S in a research note issued on Wednesday, February 12th. Wedbush analyst Y. Zhong now forecasts that the biotechnology company will post earnings per share of ($1.76) for the quarter, down from their […]
